Hi Pharmargeddon
In case you are referring to my original post on this thread thanks for contributing your referenced article.
Yes, I would agree the full importance of Midkine is yet to unfold.
Given though, there is currently a global health crisis re COVID 19 and variants I would direct you to Cellmid ASX Release of 7 November 2018 NEW PATENTS FOR MIDKINE ANTIBODIES IN USA AND EUROPE.
Cheers
Finny
- Forums
- ASX - By Stock
- AN1
- Midkine and COVID 19
Midkine and COVID 19, page-43
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online